Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.

Antunes J, Gaspar VM, Ferreira L, Monteiro M, Henrique R, Jerónimo C, Mano JF.

Acta Biomater. 2019 Jun 12. pii: S1742-7061(19)30422-2. doi: 10.1016/j.actbio.2019.06.012. [Epub ahead of print]

PMID:
31200118
2.

Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype.

Vieira-Silva TS, Monteiro-Reis S, Barros-Silva D, Ramalho-Carvalho J, Graça I, Carneiro I, Martins AT, Oliveira J, Antunes L, Hurtado-Bagès S, Buschbeck M, Henrique R, Jerónimo C.

Cancer Cell Int. 2019 Apr 29;19:112. doi: 10.1186/s12935-019-0835-9. eCollection 2019.

3.

Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer.

Avogbe PH, Manel A, Vian E, Durand G, Forey N, Voegele C, Zvereva M, Hosen MI, Meziani S, De Tilly B, Polo G, Lole O, Francois P, Delhomme TM, Carreira C, Monteiro-Reis S, Henrique R, Abedi-Ardekani B, Byrnes G, Foll M, Weiderpass E, McKay J, Jeronimo C, Scelo G, Le Calvez-Kelm F.

EBioMedicine. 2019 May 15. pii: S2352-3964(19)30305-6. doi: 10.1016/j.ebiom.2019.05.004. [Epub ahead of print]

4.

The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma.

Lameirinhas A, Miranda-Gonçalves V, Henrique R, Jerónimo C.

Genes (Basel). 2019 Apr 2;10(4). pii: E264. doi: 10.3390/genes10040264. Review.

5.

Known epigenetic biomarkers for prostate cancer detection and management: exploring the potential of blood-based liquid biopsies.

Constâncio V, Barros-Silva D, Jerónimo C, Henrique R.

Expert Rev Mol Diagn. 2019 May;19(5):367-375. doi: 10.1080/14737159.2019.1604224. Epub 2019 Apr 14.

PMID:
30961397
6.

m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance.

Lobo J, Costa AL, Cantante M, Guimarães R, Lopes P, Antunes L, Braga I, Oliveira J, Pelizzola M, Henrique R, Jerónimo C.

J Transl Med. 2019 Mar 12;17(1):79. doi: 10.1186/s12967-019-1837-z.

7.

Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.

Rodrigues D, Pinto J, Araújo AM, Monteiro-Reis S, Jerónimo C, Henrique R, de Lourdes Bastos M, de Pinho PG, Carvalho M.

Metabolomics. 2018 Apr 17;14(5):62. doi: 10.1007/s11306-018-1361-9.

PMID:
30830384
8.

GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells.

Rodrigues D, Pinto J, Araújo AM, Jerónimo C, Henrique R, Bastos ML, Guedes de Pinho P, Carvalho M.

Metabolites. 2019 Jan 18;9(1). pii: E18. doi: 10.3390/metabo9010018.

9.

Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers (Review).

Fontes-Sousa M, Amorim M, Salta S, Palma De Sousa S, Henrique R, Jerónimo C.

Oncol Rep. 2019 Mar;41(3):1431-1438. doi: 10.3892/or.2019.6967. Epub 2019 Jan 11. Review.

PMID:
30664168
10.

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer.

Monteiro-Reis S, Lobo J, Henrique R, Jerónimo C.

Int J Mol Sci. 2019 Jan 13;20(2). pii: E297. doi: 10.3390/ijms20020297. Review.

11.

Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic.

Lobo J, Gillis AJM, Jerónimo C, Henrique R, Looijenga LHJ.

Int J Mol Sci. 2019 Jan 10;20(2). pii: E258. doi: 10.3390/ijms20020258. Review.

12.

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors.

Lobo J, Henrique R, Jerónimo C.

Cancers (Basel). 2018 Dec 20;11(1). pii: E6. doi: 10.3390/cancers11010006. Review.

13.

MSH2 Expression and Resistance to Cisplatin in Muscle-invasive Bladder Cancer: A Mix of Progress and Challenges.

Henrique R, Nunes SP, Jerónimo C.

Eur Urol. 2019 Feb;75(2):251-252. doi: 10.1016/j.eururo.2018.11.014. Epub 2018 Nov 20. No abstract available.

PMID:
30470617
14.

Integrative epigenetic taxonomy of primary prostate cancer.

Stelloo S, Nevedomskaya E, Kim Y, Schuurman K, Valle-Encinas E, Lobo J, Krijgsman O, Peeper DS, Chang SL, Feng FY, Wessels LFA, Henrique R, Jerónimo C, Bergman AM, Zwart W.

Nat Commun. 2018 Nov 21;9(1):4900. doi: 10.1038/s41467-018-07270-2.

15.

The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors.

Lobo J, Barros-Silva D, Henrique R, Jerónimo C.

Genes (Basel). 2018 Nov 13;9(11). pii: E552. doi: 10.3390/genes9110552. Review.

16.

DNA methylation profiling as a tool for testicular germ cell tumors subtyping.

Costa AL, Moreira-Barbosa C, Lobo J, Vilela-Salgueiro B, Cantante M, Guimarães R, Lopes P, Braga I, Oliveira J, Antunes L, Henrique R, Jerónimo C.

Epigenomics. 2018 Dec;10(12):1511-1523. doi: 10.2217/epi-2018-0034. Epub 2018 Nov 12.

PMID:
30418048
17.

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.

Salta S, P Nunes S, Fontes-Sousa M, Lopes P, Freitas M, Caldas M, Antunes L, Castro F, Antunes P, Palma de Sousa S, Henrique R, Jerónimo C.

J Clin Med. 2018 Nov 7;7(11). pii: E420. doi: 10.3390/jcm7110420.

18.

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.

Moreira-Barbosa C, Barros-Silva D, Costa-Pinheiro P, Torres-Ferreira J, Constâncio V, Freitas R, Oliveira J, Antunes L, Henrique R, Jerónimo C.

Clin Epigenetics. 2018 Oct 29;10(1):132. doi: 10.1186/s13148-018-0564-2.

19.

Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets.

Miranda-Gonçalves V, Lameirinhas A, Henrique R, Jerónimo C.

Front Genet. 2018 Oct 9;9:427. doi: 10.3389/fgene.2018.00427. eCollection 2018. Review.

20.

Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.

Nunes SP, Moreira-Barbosa C, Salta S, Palma de Sousa S, Pousa I, Oliveira J, Soares M, Rego L, Dias T, Rodrigues J, Antunes L, Henrique R, Jerónimo C.

Cancers (Basel). 2018 Sep 26;10(10). pii: E357. doi: 10.3390/cancers10100357.

Supplemental Content

Loading ...
Support Center